1. World Health Organization. Safety of medicines. A guide to detecting and reporting adverse drug reactions (WHO/EDM/QSM/2002.2). Geneva: World Health Organization; 2002.
2. Federal Ministry of Health. Nigerian National Pharmacovigilance Policy and Implementation Framework. 2020. https://msh.org/wp-content/uploads/2021/03/nigerian_national_pharmacogilance_policy_implementation_framework.pdf. Accessed 10 July 2023.
3. World Health Organization. WHO pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems (ISBN 9789241508254). https://apps.who.int/iris/bitstream/handle/10665/186642/9789241508254_eng.pdf. Accessed 10 July 2023.
4. Fukushima A, Iessa N, Balakrishnan MR, et al. Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience. BMC Med Inform Decis Mak. 2022;22(1):118. https://doi.org/10.1186/s12911-022-01832-7.
5. Gahr M, Eller J, Connemann BJ, et al. Underreporting of adverse drug reactions: results from a survey among physicians. Eur Psychiatry. 2017;2017(41 Suppl):S369. https://doi.org/10.1016/j.eurpsy.2017.02.377.